MiCAN Technologies
Business Services · Japan · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1-36 Goryouoohara Kyoto, Goryouooharacho...Phone Number
+81 753813008Website
www.micantechnologies.comRevenue
<$5 MillionIndustry
About MiCAN Technologies
MiCAN Technologies Org Chart
Is MiCAN Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if MiCAN Technologies is spiking on competitors!
Product Launch: Get notified when MiCAN Technologies launches new products
Congratulate Masked Content for being promoted to Masked Content at MiCAN Technologies
MiCAN Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on MiCAN Technologies recently announced quarterly report
Check if MiCAN Technologies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if MiCAN Technologies had a recent Job posting/layoffs
Funding: Get notified immidiatlly once MiCAN Technologies has new funding data
Recommended Actions
Reach out to Masked Content who joined MiCAN Technologies as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
MiCAN Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MiCAN Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MiCAN Technologies.
MiCAN Technologies Tech Stack
A closer look at the technologies used by MiCAN Technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MiCAN Technologies
MiCAN Technologies specializes in the production of unique blood cell types using proprietary monocytic cell lines (aMylc) to enhance the efficiency and stability of infection research and drug development. Their regenerative medicine technology allows for the mass production of high-quality specialized blood cells, which are utilized in pharmaceut... Read More